Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-010596
Filing Date
2025-01-29
Accepted
2025-01-29 17:29:23
Documents
2
Period of Report
2025-01-27

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4589
2 EX-24 irwd-ex24.htm EX-24 10306
  Complete submission text file 0000950170-25-010596.txt   16310
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER STREET SUITE 2300 BOSTON MA 02110
Business Address
Martini Gregory S. (Reporting) CIK: 0002053936 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34620 | Film No.: 25570452